Carroll Financial Associates’s Genocea Biosciences, Inc. GNCA Stock Holding History

Carroll Financial Associates’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-375	Closed	–	–	1795
2019 Q4	$0	Hold	375	–	–	﹤0.01%	1784
2019 Q3	$1K	Hold	375	–	–	﹤0.01%	1493
2019 Q2	$1K	Hold	375	–	–	﹤0.01%	1550
2019 Q1	$1K	Hold	375	–	–	﹤0.01%	1349
2018 Q4	$1K	Sell	375 -250	-40%	-$1.24K	﹤0.01%	1282
2018 Q3	$3K	Hold	625	–	–	﹤0.01%	1182
2018 Q2	$4K	Hold	625	–	–	﹤0.01%	1112
2018 Q1	$5K	Hold	625	–	–	﹤0.01%	1050
2017 Q4	$5K	Hold	625	–	–	﹤0.01%	1015
2017 Q3	$9K	Buy	625 +375	+150%	+$14.2K	﹤0.01%	851
2017 Q2	$10K	Buy	+250	New	+$12K	﹤0.01%	844

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Carroll Financial Associates's GNCA Position: Q1 2020 in Review

Carroll Financial Associates sold out of Genocea Biosciences, Inc. (GNCA) in Q1 2020, closing a stake of 375 shares.

Carroll Financial Associates first reported a position in GNCA in Q2 2017 and held it in 11 quarters. The position peaked at $10K in Q2 2017. 33 funds tracked by Wall St. Rank hold GNCA as of Q1 2020.

Carroll Financial Associates reported no remaining Genocea Biosciences, Inc. position as of Q1 2020 after selling out during the quarter.
Carroll Financial Associates sold 375 Genocea Biosciences, Inc. shares in Q1 2020.
Carroll Financial Associates first reported a position in Genocea Biosciences, Inc. in Q2 2017 and held it in 11 quarters.
Carroll Financial Associates's Genocea Biosciences, Inc. position peaked at $10K in Q2 2017.
33 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2020.

Based on Carroll Financial Associates's 13F filing for Q1 2020, filed 10 Apr 2020.